Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Agilent Will Acquire Seahorse Bioscience
by Marc S. Reisch
September 14, 2015
| A version of this story appeared in
Volume 93, Issue 36
Agilent Technologies has agreed to acquire Billerica, Mass.-based Seahorse Bioscience for $235 million in cash. Seahorse makes analyzers that measure cell metabolism to better understand cell health, function, and signaling. Founded in 2001, it employs about 200 people and is expected to have sales of $49 million this year. Combining Seahorse’s metabolic analysis instruments with Agilent’s separations and mass spectrometry equipment will help scientists research challenging diseases, Agilent says.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter